Onderneming Centrexion Therapeutics Corporation
Aandelen
CNTX
US15643W1009
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 24
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 76 | 01-02-13 | |
Jeffrey Kindler
FOU | Founder | 68 | 01-02-13 |
Chief Tech/Sci/R&D Officer | - | 01-04-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Swedish
BRD | Director/Board Member | 72 | 26-06-18 |
Sol Barer
FOU | Founder | 76 | 01-02-13 |
Jeffrey Kindler
FOU | Founder | 68 | 01-02-13 |
Peter Wirth
BRD | Director/Board Member | 73 | - |
Director/Board Member | 83 | 01-02-13 | |
Daniel Mendelson
BRD | Director/Board Member | 60 | 15-08-18 |
Hong Bo Lu
BRD | Director/Board Member | 53 | 01-01-19 |
Founder | 76 | 01-02-13 | |
Sara Nayeem
BRD | Director/Board Member | 75 | 01-01-18 |
Shawn Tomasello
BRD | Director/Board Member | 65 | 26-06-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 669 866 | 0 | 0 | - |
Bedrijfsgegevens
Centrexion Therapeutics Corp.
200 State Street 6th floor
02109, Boston
+617-837-6911
http://www.centrexion.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,70% | 41,35 mld. | |
+41,70% | 40,38 mld. | |
+2,99% | 39,05 mld. | |
-12,11% | 26,67 mld. | |
+1,94% | 24,07 mld. | |
-23,68% | 18,36 mld. | |
-3,33% | 11,68 mld. | |
+21,22% | 11,6 mld. | |
+7,32% | 11,15 mld. |